Neonatal abstinence syndrome: Difference between revisions
| Line 55: | Line 55: | ||
*Klein, J. Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines. University of Iowa Children's Hospital 2/11/13. http://www.uichildrens.org/uploadedFiles/UIChildrens/Health_Professionals/Iowa_Neonatology_Handbook/Pharmacology/Neonatal%20Abstinence%20Syndrome%20Treatment%20Guidelines%20Feb2013%20revision.pdf | *Klein, J. Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines. University of Iowa Children's Hospital 2/11/13. http://www.uichildrens.org/uploadedFiles/UIChildrens/Health_Professionals/Iowa_Neonatology_Handbook/Pharmacology/Neonatal%20Abstinence%20Syndrome%20Treatment%20Guidelines%20Feb2013%20revision.pdf | ||
*Perinatal Quality Collaborative of North Carolina. Best Practice Neonatal Abstinence Syndrome. Document online. | *Perinatal Quality Collaborative of North Carolina. Best Practice Neonatal Abstinence Syndrome. Document online. | ||
[[Category:Peds]] | |||
[[Category:Tox]] | |||
Revision as of 19:01, 24 March 2015
Background
- Polysubstance combining opiates and cocaine must be considered
- Withdrawal within first 24-48 hrs --> fetal alcohol syndrome
- Withdrawal within 48-72 hrs --> heroin
- Withdrawal at 7-14 days --> methadone
Clinical Presentation
- Agitated - high-pitched cry, restlessness, tremors, hypertonia, convulsions
- Vasomotor - sweating, fever
- Respiratory - nasal congestion, persistent sneezing, RR > 60/min, nasal flaring
- Metabolic - poor feeding, vomiting, loose stools
Differential Diagnosis
- Neonatal sepsis
- Hyperthyroidism/hypothyroidism
- Hypocalcemia
- Hypoglycemia
- Vertically transmitted diseases (HepB, HepC, HIV, etc.)
- Other withdrawal (caffeine, cocaine, nicotine, amphetamines, SSRIs)
Diagnosis
- Pharmacologic treatment when 3 consecutive ≥ 8 on NAS(Finnegan scale
- Enzyme immunoassay, urine toxicology, meconium analysis
- Consider cranial US for cocaine-exposed neonates with abnormal neurologic signs
Treatment
- Supportive - swaddling to decrease sensory stimulation, frequent small feedings of 24 cal/oz formula
- Opiates when supportive measures fail
- Morphine is 1st line for infants exposed to both opiates and benzos
- Neonatal morphine 0.4 mg/ml PO sln
- Watch for side effect limiting dose (urinary retention)
- Withdrawal symptoms need to be stabilized for 3-5 days before taper
- Mother's methadone < 50 mg (or other opiate)
- Start morphine PO sln 0.1 mg/kg q3hrs with feeds
- Increase by 0.1 mg/kg hourly if NAS score ≥ 8, max 1 mg/kg
- Mother's methadone > 50 mg
- Start 0.2 mg/kg q3hrs
- Increase by 0.2 mg/kg hourly if NAS score ≥ 8, max 1 mg/kg
- If NPO, use preservative free morphine at 50 mcg/ml
- Load 30 mcg/kg over 1hr, then infusion at 2 mcg/kg/hr
- Increase by 1 mcg/kg/hr hourly until NAS < 8, max 6 mcg/kg/hr
- Neonatal morphine 0.4 mg/ml PO sln
- Benzo withdrawal treatment
- Midazolam 0.1 mg/kg IV q3hrs or 0.3 mg/kg PO q3hrs
- OR phenobarbital 3 mg/kg IV or PO q24hrs
- Phenobarbital for seizures OR side effect limiting morphine effects OR max morphine dose reached
- 16 mg/kg load divided into two consecutive feedings for day 1
- 24 hrs later, use 2-8 mg/kg/day maintenance dose
See Also
Sources
- Hudak et al. Neonatal Drug Withdrawal AAP Policy. PEDIATRICS Vol. 129 No. 2 February 1, 2012, pp. e540 -e560.
- Hamdan et al. Neonatal Abstinence Syndrome. Medscape 2014. http://emedicine.medscape.com/article/978763-overview#showall.
- Klein, J. Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines. University of Iowa Children's Hospital 2/11/13. http://www.uichildrens.org/uploadedFiles/UIChildrens/Health_Professionals/Iowa_Neonatology_Handbook/Pharmacology/Neonatal%20Abstinence%20Syndrome%20Treatment%20Guidelines%20Feb2013%20revision.pdf
- Perinatal Quality Collaborative of North Carolina. Best Practice Neonatal Abstinence Syndrome. Document online.
